Cargando…
Connective tissue presentation in two families expands the phenotypic spectrum of PYROXD1 disorders
Recessive variants in the oxidoreductase PYROXD1 are reported to cause a myopathy in 22 affected individuals from 15 families. Here, we describe two female probands from unrelated families presenting with features of a congenital connective tissue disorder including osteopenia, blue sclera, soft ski...
Autores principales: | Evesson, Frances J, Dziaduch, Gregory, Bryen, Samantha J, Moore, Francesca, Pittman, Sara, Devanapalli, Beena, Waddell, Leigh B, Ryan, Monique M, Menezes, Manoj P, Weihl, Conrad C, Tolun, Adviye Ayper, Zaidman, Craig, Young, Helen, Adès, Lesley C, Cooper, Sandra T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244218/ https://www.ncbi.nlm.nih.gov/pubmed/36920481 http://dx.doi.org/10.1093/hmg/ddad035 |
Ejemplares similares
-
A narrative review of metabolomics in the era of “-omics”: integration into clinical practice for inborn errors of metabolism
por: Hertzog, Ashley, et al.
Publicado: (2022) -
The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders
por: Bhattacharya, Kaustuv, et al.
Publicado: (2020) -
Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning
por: Sajeev, Mona, et al.
Publicado: (2021) -
Clinical, histological, and genetic characterization of PYROXD1-related myopathy
por: Lornage, Xavière, et al.
Publicado: (2019) -
Treatment of HMG-CoA Lyase Deficiency—Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases
por: Thompson, Susan, et al.
Publicado: (2023)